G. A. Otieno

Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial

K. Bojang, T. Taylor, B. Mordmüller, 2016, PLoS medicine.

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study

L. Otieno, B. Ogutu, D. J. Perkins, 2014, Malaria Journal.

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Vaccine.

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Human vaccines & immunotherapeutics.

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01

W. Otieno, L. Otieno, Nekoye Otsyula, 2013, Malaria Journal.